BACKGROUND: Tick-borne encephalitis virus (TBEV) infections may be asymptomatic or cause severe symptoms in the central nervous system. A mutation in the chemokine receptor 5 gene has been associated with increased risk of TBE but explains only a limited number of cases. Investigations of further risk factors are needed. METHOD: To investigate the importance of the innate immune response, we analyzed 128 TBE patients, 77 patients with aseptic meningoencephalitis (AME) and 135 healthy controls, for 3 mutations: 2 in the Toll-like receptor 3 (TLR3) gene and 1 in the 2'-5'-oligoadenylate synthetase (OAS1) gene. RESULTS: Although no association was found between the mutation in the OAS1 gene and TBE, the genotype distribution ofrs3775291, a mutation in TLR3, differed significantly between TBE patients and controls; 61%, 32%, and 7% of the TBE patients were carriers of the wild-type, heterozygous, and mutant genotype of rs3775291, respectively. The corresponding percentages among healthy controls (n = 126) were 52%, 29%, and 19% (P = .02), and among AME patients (n = 75) were 47%, 32%, and 21% (P = .009). Additionally, the wild-type rs3775291 allele was more common among TBE patients than among healthy controls (allele frequency, .768 vs .663; P = .01). CONCLUSION: A functional TLR3 is a risk factor for TBEV infection.
BACKGROUND:Tick-borne encephalitis virus (TBEV) infections may be asymptomatic or cause severe symptoms in the central nervous system. A mutation in the chemokine receptor 5 gene has been associated with increased risk of TBE but explains only a limited number of cases. Investigations of further risk factors are needed. METHOD: To investigate the importance of the innate immune response, we analyzed 128 TBEpatients, 77 patients with aseptic meningoencephalitis (AME) and 135 healthy controls, for 3 mutations: 2 in the Toll-like receptor 3 (TLR3) gene and 1 in the 2'-5'-oligoadenylate synthetase (OAS1) gene. RESULTS: Although no association was found between the mutation in the OAS1 gene and TBE, the genotype distribution ofrs3775291, a mutation in TLR3, differed significantly between TBEpatients and controls; 61%, 32%, and 7% of the TBEpatients were carriers of the wild-type, heterozygous, and mutant genotype of rs3775291, respectively. The corresponding percentages among healthy controls (n = 126) were 52%, 29%, and 19% (P = .02), and among AMEpatients (n = 75) were 47%, 32%, and 21% (P = .009). Additionally, the wild-type rs3775291 allele was more common among TBEpatients than among healthy controls (allele frequency, .768 vs .663; P = .01). CONCLUSION: A functional TLR3 is a risk factor for TBEV infection.
Authors: Hordur S Hardarson; J Scott Baker; Zhao Yang; Enkhsaikhan Purevjav; Chien-Hua Huang; Lena Alexopoulou; Na Li; Richard A Flavell; Neil E Bowles; Jesus G Vallejo Journal: Am J Physiol Heart Circ Physiol Date: 2006-08-25 Impact factor: 4.733
Authors: C T Ranjith-Kumar; William Miller; Jingchuan Sun; Jin Xiong; Jon Santos; Ian Yarbrough; Roberta J Lamb; Juliane Mills; Karen E Duffy; Scott Hoose; Mark Cunningham; Andreas Holzenburg; M Lamine Mbow; Robert T Sarisky; C Cheng Kao Journal: J Biol Chem Date: 2007-04-13 Impact factor: 5.157
Authors: Lin Liu; Istvan Botos; Yan Wang; Joshua N Leonard; Joseph Shiloach; David M Segal; David R Davies Journal: Science Date: 2008-04-18 Impact factor: 47.728